Global Ganja Report

Seniors are the fastest growing group of medicinal cannabis users in the country, and a growing number of nursing homes from coast to coast are tolerating use of tinctures and extracts to combat dementia, insomnia and related ailments. Patient testimony is now backed up by research, with scientists identifying the mechanism by which cannabinoids slow the deterioration of neurons in the brain. But federal strictures continue to pose an obstacle to investigation—leaving medicinal users in the cold under US law.

Another dispensary is raided by police in Toronto—the latest in a string of such busts in the city over the past months, with some outlets even shut down. It's an irony that this crackdown comes as Canada is in its final countdown to legalization, and opens questions about whether there will be a place for independent dispensaries and small growers under the imminent new regulation regime.

A United Nations study brings back the surprise finding that the world's biggest producer of legal cannabis is Great Britain. The answer to this seeming anomaly lies in one UK-based multinational corporation with industrial-scale grow operations for production of pharmaceuticals.

Panama may be the next Latin American country to pass a medical marijuana law, with the nation's National Assembly now debating a measure. But, in sharp contrast to that in neighboring Colombia, the Panamanian program would fly pretty close to the ground. In a play to social conservatives, the law would only allow imports, and users would be limited to extracts rather than herbaceous cannabis. And even this may face a fight from opposition lawmakers.

Several Vietnamese immigrants who had been living legally for many years in the United States have been detained by the federal government and are facing possible deportation back to Vietnam—where they may face persecution. They've launched suit against the government over their detention and state of "legal limbo." The government says they violated terms of their status by committing crimes—including growing small quantities of cannabis.

In a sure sign of changing times, the first cannabis-industry business has been listed on the NASDAQ stock exchange—raising clear questions about how long prohibition can hang on in the face of a burgeoning economic sector. Toronto-based medical marijuana producer Cronos Group won approval from the US Securities and Exchange Commission (SEC) to become the first cannabis company listed on NASDAQ, New York City's second biggest stock market, Bloomberg reported Feb. 26.

Despite repeated pledges by the New York Police Department and Mayor Bill de Blasio to lift the police pressure on cannabis, and especially to address the long-standing racial disparity in pot busts, all too little seems to be changing in Gotham. In a sometimes heated session, New York's City Council held hearings Feb. 26 to discuss new stats showing that despite a significant drop in cannabis arrests, the overwhelming majority of those busted remain Black and Latino.

A judge for the US District Court for the Southern District of New York on Feb. 26 dismissed a lawsuit challenging the Schedule I classification for cannabis under the Controlled Substances Act. Judge Alvin Hellerstein granted the government's motion to dismiss because the plaintiffs failed to exhaust all administrative remedies prior to initiating the suit. The "exhaustion rule" requires "that parties exhaust prescribed administrative remedies before seeking relief from federal courts."